Literature DB >> 12167793

Coagulation, fibrinolysis, and cell activation in patients and shed mediastinal blood during coronary artery bypass grafting with a new heparin-coated surface.

Matilda Johnell1, Graciela Elgue, Rolf Larsson, Anders Larsson, Stefan Thelin, Agneta Siegbahn.   

Abstract

OBJECTIVES: Heparin coating of the cardiopulmonary bypass circuit is shown to improve the biocompatibility of the surface. We have studied a new heparin surface, the Corline Heparin Surface, applied to a complete set of an extracorporeal device used during coronary artery bypass grafting in terms of activation of inflammation, coagulation, and fibrinolysis in patients and in shed mediastinal blood.
METHODS: Sixty patients scheduled for coronary artery bypass grafting were randomized to one of 3 groups with heparin-coated devices receiving either a standard, high, or low dose of systemic heparin or to an uncoated but otherwise identical circuit receiving a standard dose of systemic heparin. Samples were drawn before, during, and after the operation from the pericardial cavity and in shed mediastinal blood. No autotransfusion of shed mediastinal blood was performed.
RESULTS: The Corline Heparin Surface significantly reduced the activation of coagulation, fibrinolysis, platelets, and inflammation compared with that seen with the uncoated surface in combination with a standard dose of systemic heparin during cardiac surgery with cardiopulmonary bypass. Both a decrease and an increase of systemic heparin in combination with the coated heparin surface resulted in higher activation of these processes. A significantly higher expression of all studied parameters was found in the shed mediastinal blood compared with in systemic blood at the same time.
CONCLUSIONS: The Corline Heparin Surface used in cardiopulmonary bypass proved to be more biocompatible than an uncoated surface when using a standard systemic heparin dose. The low dose of systemic heparin might not be sufficient to maintain the antithrombotic activity, and the high dose resulted in direct cell activation rather than a further anti-inflammatory and anticoagulatory effect.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12167793     DOI: 10.1067/mtc.2002.122551

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  8 in total

Review 1.  Coagulation and fibrinolytic protein kinetics in cardiopulmonary bypass.

Authors:  Maryam Yavari; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2008-01-23       Impact factor: 2.300

2.  A new method for incorporating functional heparin onto the surface of islets of Langerhans.

Authors:  Sanja Cabric; Torsten Eich; Javier Sanchez; Bo Nilsson; Olle Korsgren; Rolf Larsson
Journal:  Tissue Eng Part C Methods       Date:  2008-06       Impact factor: 3.056

3.  Attachment of flexible heparin chains to gelatin scaffolds improves endothelial cell infiltration.

Authors:  Jonas Leijon; Fredrik Carlsson; Johan Brännström; Javier Sanchez; Rolf Larsson; Bo Nilsson; Peetra U Magnusson; Magnus Rosenquist
Journal:  Tissue Eng Part A       Date:  2013-02-26       Impact factor: 3.845

4.  Is elimination of cardiotomy suction preferable in aortic valve replacement? Assessment of perioperative coagulation, fibrinolysis and inflammation.

Authors:  Akimasa Morisaki; Atsushi Nakahira; Yasuyuki Sasaki; Hidekazu Hirai; Yuko Okada; Shigefumi Suehiro; Toshihiko Shibata
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-05-31

5.  Role of heparin in pulmonary cell populations in an in-vitro model of acute lung injury.

Authors:  Marta Camprubí-Rimblas; Raquel Guillamat-Prats; Thomas Lebouvier; Josep Bringué; Laura Chimenti; Manuela Iglesias; Carme Obiols; Jessica Tijero; Lluís Blanch; Antonio Artigas
Journal:  Respir Res       Date:  2017-05-10

6.  Surface modification of pig endothelial cells with a branched heparin conjugate improves their compatibility with human blood.

Authors:  Anjan K Bongoni; Evelyn Salvaris; Sofia Nordling; Nikolai Klymiuk; Eckhard Wolf; David L Ayares; Robert Rieben; Peetra U Magnusson; Peter J Cowan
Journal:  Sci Rep       Date:  2017-06-30       Impact factor: 4.379

Review 7.  Coronary artery surgery: cardiotomy suction or cell salvage?

Authors:  Kelvin Lau; Hetul Shah; Andrea Kelleher; Neil Moat
Journal:  J Cardiothorac Surg       Date:  2007-10-25       Impact factor: 1.637

8.  Flow-induced platelet activation in components of the extracorporeal membrane oxygenation circuit.

Authors:  Gabriel Fuchs; Niclas Berg; L Mikael Broman; Lisa Prahl Wittberg
Journal:  Sci Rep       Date:  2018-09-18       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.